167 related articles for article (PubMed ID: 31133625)
1. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study.
Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E
J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625
[TBL] [Abstract][Full Text] [Related]
2. Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016.
Jafari S; Moradi G; Zareie B; Gouya MM; Zavareh FA; Ghaderi E
An Bras Dermatol; 2020; 95(3):289-297. PubMed ID: 32276795
[TBL] [Abstract][Full Text] [Related]
3. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
[TBL] [Abstract][Full Text] [Related]
4. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
5. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Associated Factors of HIV Infection among Male Prisoners in Tehran, Iran.
SeyedAlinaghi S; Farhoudi B; Mohraz M; Golsoorat Pahlaviani F; Hosseini M; Farnia M; Shahbazi M; Alasvand R; Tashakoriyan M
Arch Iran Med; 2017 Jun; 20(6):356-360. PubMed ID: 28646844
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
Khademi N; Skakiba E; Khodadoust M; Khoramdad M
Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
[TBL] [Abstract][Full Text] [Related]
11. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
12. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Drug Use and Related Factors Among Prisoners in Iran: Results from the National Survey in 2015.
Moradi G; Darvishi S; Asaadi L; Azimian Zavareh F; Gouya MM; Tashakorian M; Alasvand R; Mohamadi Bolbanabad A
J Prim Prev; 2020 Feb; 41(1):29-38. PubMed ID: 31912408
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
15. Patterns of sexual behaviors and related factors among prisoners in Iran: results from a national survey in 2015.
Moradi G; Mohamadi-Bolbanabad A; Darvishi S; Azimian Zavareh F; Piroozi B; Zareie B; Gouya MM; Tashakorian M
Int J Prison Health; 2019 Sep; 16(1):29-37. PubMed ID: 32040273
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
19. High-risk drug-use practices among a large sample of Australian prisoners.
Kinner SA; Jenkinson R; Gouillou M; Milloy MJ
Drug Alcohol Depend; 2012 Nov; 126(1-2):156-60. PubMed ID: 22658284
[TBL] [Abstract][Full Text] [Related]
20. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
